digiMedical Solutions, Inc. Announces Sales Channel Agreement With 1,500 Offices Nationwide
15 Giugno 2009 - 3:00PM
Marketwired
digiMedical Solutions, Inc.(TM) (PINKSHEETS: DGMS), today released
a letter to shareholders from Company CEO David Lee. The letter
provides an operational update on the Company's proprietary digital
prescription software suite and increased sales channels. The
letter is included in its entirety below.
Separately, the Company recently launched a new interactive
digital prescription website allowing doctors and pharmacists to
sign up online to use digiMedical's products. The new site,
www.digiReAuth.com, is part of an ongoing effort by the Company to
market digiRX, a thin client suite of products providing digital
prescription and reauthorization services to doctors, pharmacists
and patients. Utilizing the latest Microsoft technologies such as
.NET, AJAX and Microsoft SQL, the Company has developed a suite of
products to digitally manage the prescription process. The
Company's products comply with all HIPAA and DEA requirements for
patient medical record security.
Dear Fellow Shareholders,
In my shareholder letter released March 24th of this year, I
outlined what directions digiMedical would be undertaking for 2009.
Let me recap these directions for you and give you an update as to
our progress.
Quarter One Activity
In recent months, the Company announced that it is growing its
advisory board, with the most recent addition being Jason
Whisenant, www.digiMedical.com/News/News.aspx. He and others like
him will help expand the Company's ability to forecast future
trends and marketing segments in the digital prescription industry,
while at the same time improving our sales and marketing
division.
Over the course of the first quarter, the Company also launched
our new corporate website www.digiMedical.com, detailing our
proprietary digital prescription software. We also launched two
other vital websites www.digiRX.com and www.digiReAuth.com. These
websites allow doctors and pharmacists to find out about our
products and services and sign up via the Web. These websites
leverage our software and significantly expand our ability to sell
to and service the market with minimal backend manpower, resulting
in a strong platform allowing for exponential sales growth.
Quarter Two Activity
Board member Philip Verges, CEO of NewMarket Technology
(PINKSHEETS: NMKT), introduced VirtualHealth (OTCBB: VHGI) and our
Company. VirtualHealth has a medical practice management system
software product with a large client base (for more information
visit http://www.mosonline.com). I am pleased to announce a new,
signed contract with VirtualHealth to offer our software and
services in conjunction with their software to their client base of
over 1,500 offices nationwide.
This is a significant move for digiMedical to increase our sales
channels and our software's visibility in the market. In the third
quarter, we will contiue to work on this new sales channel to sign
on more doctors. We plan to issue more information on this
agreement in the future and we will continue to look for other
large sales channels to partner with.
Additionally, in quarter three, we are planning to roll out a
new version, 3.0, of our digiRX product.
Summary
digiMedical is focused on expanding our market share through
reselling our software products digiRX, digiReAuth and digiPRN
Pharmacies by forging agreements with partners that have an
existing client base and sales channels, like with VirtualHealth,
that will significanlty increase our sales and visibility in the
market.
We recognize this is a difficult economy, and therefore perhaps
a difficult time to be a development stage company. However, we are
enthusiastic about our progress to date and consider our recent
channel agreement, in conjunction with our already proven, in
production software to be a significant milestone for the Company.
I hope shareholders share our enthusiasm and if so, I would ask you
spread the word. Everyone knows at least one doctor, so let them
know about our products. We are proud of the products we have
developed and the security and savings they have brought our
clients. digiMedical is a great story, and we have set the
foundations for a bright future.
Thank you all for your patience and support.
Best regards,
David W. Lee
CEO of digiMedical Solutions, Inc.
To be added to digiMedical's corporate e-mail list to receive
company updates, please send an e-mail to ir@digimedical.com.
About digiMedical Solutions, Inc.(TM) (www.digiMedical.com)
digiMedical Solutions, Inc.(TM) is a pharmacy and medical
technology company focused on developing next generation, digital
medical technology with an emphasis on digital prescriptions
(d-Prescriptions) that closely align the doctor, pharmacist and
patient. The company's planned growth will come from three
channels: direct marketing of the company's wireless based
d-prescription technology to physicians, direct marketing of the
company's digital call center services for refills and
reauthorization and partnering with independent pharmacy chains to
focus sales with the technology suite.
Forward-Looking Statement
Statements included in this press release which are not
historical in nature, are intended to be, and are hereby identified
as "Forward-Looking Statements" for purposes of safe harbor
provided by Section 21E of the Securities Exchange Act of 1934, as
amended. Forward-Looking Statements may be identified by words
including "anticipate," "await," "envision," "foresee," "aim at,"
"believe," "intends," "estimates" including without limitation,
those relating to the company's future business prospects, are
subject to certain risks and uncertainties that could cause actual
results to differ materially from those indicated in the
Forward-Looking Statements. Readers are directed to the company's
filings with the U.S. Securities and Exchange Commission.
Contact: digiMedical Solutions, Inc. Investor Relations
214-722-3029 ir@digimedical.com www.digimedical.com
Grafico Azioni DigiMedical Solutions (CE) (USOTC:DGMS)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni DigiMedical Solutions (CE) (USOTC:DGMS)
Storico
Da Giu 2023 a Giu 2024